SEC Company Response from IGC Pharma, Inc. (IGC) (CIK 0001326205) (IGC) — Jan 20, 2009
IGC Pharma, Inc. (IGC) (CIK 0001326205)
Date: Jan. 20, 2009 · CIK: 0001326205 · Accession: 0001185185-09-000031
AI Filing Summary & Sentiment
Reasoning
Referenced dates: January 6, 2009
Letter
January 20, 2009 Mr. Rufus Decker Accounting Branch Chief Securities and Exchange Commission
Dear Mr. Decker:
We are in receipt of your letter dated January 6, 2009. We apologize for the delay in responding, but due to international travel, we were not in receipt of your letter until January 16, 2009.
We have left a voicemail message today with Mr. Jeffrey Gordon to discuss the steps the Company and Y&R have taken and will continue to take in order to respond substantively to your comments contained in your May 14, 2008 letter. As you may be aware, representatives from Y&R spoke with Mr. Kevin Stout following your May 14, 2008 letter and received the letter outlining, among other things, the need for, and role of, the consultant.
We would like to discuss this matter further with Mr. Gordon or another Staff member, as appropriate. Despite our and Y&R's good faith efforts, including consultations with at least seven accounting firms, we and Y&R have struggled to find a U.S. accounting firm or another international firm that regularly practices before the Commission and has extensive knowledge of the requirements of U.S. GAAP, PCAOB Standards, and auditor independence regulations to accept the engagement at this time, although we continue to assist Y&R in finding such a firm.
We intend to speak with Mr. Gordon as soon as possible. In the meantime, please feel free to contact me at 301-983-0998
Sincerely,
Ram
Mukunda
Show Raw Text
CORRESP
1
filename1.htm
india-corresp1202009.htm
India
Globalization Capital
4336
Montgomery Avenue, Bethesda, Maryland 20814
Phone:
301-983-0998 Fax: 240-465-0273
IGC.U/IGC-U
(AMEX)
Ram
Mukunda
Chief
Executive Officer
ram@indiaglobalcap.com
January
20, 2009
Mr.
Rufus Decker
Accounting
Branch Chief
Securities
and Exchange Commission
Dear
Mr. Decker:
We
are in receipt of your letter dated January 6, 2009. We apologize for
the delay in responding, but due to international travel, we were not in
receipt of your letter until January 16, 2009.
We
have left a voicemail message today with Mr. Jeffrey Gordon to discuss the
steps the Company and Y&R have taken and will continue to take in
order to respond substantively to your comments contained in your May 14,
2008 letter. As you may be aware, representatives from Y&R spoke with
Mr. Kevin Stout following your May 14, 2008 letter and received the letter
outlining, among other things, the need for, and role of, the
consultant.
We
would like to discuss this matter further with Mr. Gordon or another Staff
member, as appropriate. Despite our and Y&R's good faith
efforts, including consultations with at least seven accounting firms, we
and Y&R have struggled to find a U.S. accounting firm or another
international firm that regularly practices before the Commission and has
extensive knowledge of the requirements of U.S. GAAP, PCAOB Standards, and
auditor independence regulations to accept the engagement at
this time, although we continue to assist Y&R in finding such a
firm.
We
intend to speak with Mr. Gordon as soon as possible. In the meantime,
please feel free to contact me at 301-983-0998
Sincerely,
Ram
Mukunda